Record when symptoms began and how long they lasted, not just their names. Tell a clinician about severe or persistent symptoms. Serious ongoing abdominal pain or breathing difficulty calls for care before record keeping.
Read the information for your own medicine
MedlinePlus lists nausea, vomiting, diarrhea, abdominal pain and constipation among possible adverse effects of injectable semaglutide. It advises contacting a clinician if symptoms are severe or do not go away.[1] This source concerns semaglutide injection; identical effects and instructions should not be assumed for every product.
Signs that need care before record keeping
Severe ongoing abdominal pain, pain spreading to the back, difficulty breathing or swallowing, swelling of the face, mouth or throat, or reduced urination need prompt medical assessment.[1] For breathing difficulty, impaired consciousness or other emergencies, contact your local emergency service. In South Korea, call 119. Concerning symptoms not listed here may also require care.
Useful details for a consultation
- Onset: date, time, product and time of the most recent dose.
- Severity: discomfort and effects on ordinary activities or sleep.
- Duration: how long symptoms lasted and whether they recurred.
- Intake: whether you could eat and drink, and what differed from usual.
Record observations without assuming the cause
Choose relevant symptom items in GLP1 Helper and review them by date. Write what you observed rather than concluding that the medicine caused it. Mention other medicines when discussing the record.
The app does not provide emergency monitoring or live clinical consultation. Discuss dose changes, stopping and restarting with your prescriber.
A small check-in today
- Have you recorded onset and duration?
- Have you checked whether food and fluids are possible?
- Have you sought care for severe or concerning symptoms?
Frequently asked questions
Will a clinician see my symptom entry immediately?
No. GLP1 Helper does not provide real-time medical monitoring. Use local emergency services for emergencies and contact a medical service directly when advice is needed.
The GLP1 Helper editorial team prepared this general information from public sources. It has not received individual medical-expert review. It does not replace diagnosis or prescribing. Confirm approved uses and instructions in your country with your prescriber or pharmacist. Editorial principles
References
- MedlinePlus · Semaglutide InjectionUS public drug information · Source checked 2026-10-02